Instrument hygiene knowledge reduces TASS risk

Article

Instrument hygiene education level affects the risk of toxic anterior segment syndrome (TASS).

Instrument hygiene education level affects the risk of toxic anterior segment syndrome (TASS).

The cross-sectional study, performed by Dr Zachary Bodnar et al., John A. Moran Eye Centre, University of Utah, Salt Lake City, Utah, USA, included retrospective analysis of surveys reporting TASS cases between June 2007 and March 2012. The analysis also included information from afflicted sites between October 2005 and December 2011. The results from June 2009 to March 2012 were compared to the results collected before June 2009.

A total of 130 questionnaires from 71 sites were included in the investigation. Approximately 69000 surgeries were performed and 1454 cases of TASS were reported.

In all centres there was a 36% reduction in the use of preserved epinephrine or enzymatic detergents. There was a 27% increase in centres that used a deionized or distilled final rinse for the handpieces and a 26% reduction in centres reporting inadequate handpiece flushing volumes.

There was a 21% increase in handling IOLs or instrument tips while wearing gloves, a 47% increase in poor instrument maintenance and a 34% increase in ultrasound bath use without adequate routine cleaning.

The abstract can be found in the Journal of Cataract and Refractive Surgery.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.